DE602004020070D1 - Thienopyrimidin-derivate als kaliumkanal-inhibitoren - Google Patents

Thienopyrimidin-derivate als kaliumkanal-inhibitoren

Info

Publication number
DE602004020070D1
DE602004020070D1 DE602004020070T DE602004020070T DE602004020070D1 DE 602004020070 D1 DE602004020070 D1 DE 602004020070D1 DE 602004020070 T DE602004020070 T DE 602004020070T DE 602004020070 T DE602004020070 T DE 602004020070T DE 602004020070 D1 DE602004020070 D1 DE 602004020070D1
Authority
DE
Germany
Prior art keywords
channel inhibitors
thienopyrimidine derivatives
kalium
kalium channel
thienopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004020070T
Other languages
English (en)
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xention Ltd
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of DE602004020070D1 publication Critical patent/DE602004020070D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004020070T 2003-06-11 2004-06-10 Thienopyrimidin-derivate als kaliumkanal-inhibitoren Expired - Lifetime DE602004020070D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
DE602004020070D1 true DE602004020070D1 (de) 2010-10-07

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020070T Expired - Lifetime DE602004020070D1 (de) 2003-06-11 2004-06-10 Thienopyrimidin-derivate als kaliumkanal-inhibitoren

Country Status (16)

Country Link
EP (1) EP1641803B3 (de)
KR (1) KR101186678B1 (de)
CN (1) CN1823071B (de)
AT (1) ATE425982T1 (de)
AU (1) AU2004247470B2 (de)
BR (1) BRPI0411239A (de)
CA (1) CA2528848C (de)
DE (1) DE602004020070D1 (de)
DK (1) DK1641803T3 (de)
ES (1) ES2324536T7 (de)
HK (1) HK1093064A1 (de)
MX (1) MXPA05013549A (de)
PL (1) PL1641803T6 (de)
SI (1) SI1641803T1 (de)
WO (1) WO2004111057A1 (de)
ZA (1) ZA200600225B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
WO2006004658A2 (en) * 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines
EP1802632B1 (de) * 2004-10-21 2011-07-13 Dow AgroSciences LLC Thenopyrimidin-verbindungen mit fungizider aktivität
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
JP2009507849A (ja) * 2005-09-09 2009-02-26 ブリストル−マイヤーズ スクイブ カンパニー 非環状IKurインヒビター
GB0525164D0 (en) * 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
US8883852B2 (en) 2008-10-22 2014-11-11 University of Pittburgh—Of the Commonwealth System of Higher Education Radioprotective agents
EP2405973B1 (de) 2009-03-13 2015-04-22 Katholieke Universiteit Leuven, K.U. Leuven R&D Thiazolopyrimidin-modulatoren als immunsuppressive mittel
HUE032983T2 (en) 2009-09-03 2017-11-28 Bristol Myers Squibb Co Quinazoline as potassium ion channel inhibitor
LT2540728T (lt) * 2010-02-17 2019-06-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) * 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (de) 2011-07-01 2018-04-28
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
WO2013072693A1 (en) * 2011-11-15 2013-05-23 Xention Limited Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors
WO2013078126A1 (en) 2011-11-23 2013-05-30 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase c
EP2806865A1 (de) 2012-01-27 2014-12-03 Gilead Sciences, Inc. Kombinationstherapien mit späten ionenkanalblockern und kaliumionenkanalblockern
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
US20160002273A1 (en) * 2013-03-07 2016-01-07 Glaxosmithkline Llc Thieno[3,2-d]pyrimidine-6-carboxamides and analogues as sirtuin modulators
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
WO2001046155A1 (en) * 1999-12-21 2001-06-28 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
CN1823071B (zh) 2012-12-19
ZA200600225B (en) 2007-04-25
KR101186678B1 (ko) 2012-09-27
PL1641803T3 (pl) 2009-08-31
DK1641803T3 (da) 2009-06-29
PL1641803T6 (pl) 2011-04-29
ES2324536T3 (es) 2009-08-10
ATE425982T1 (de) 2009-04-15
AU2004247470B2 (en) 2009-04-23
CA2528848C (en) 2012-09-04
EP1641803A1 (de) 2006-04-05
SI1641803T1 (sl) 2009-08-31
MXPA05013549A (es) 2006-04-05
AU2004247470A1 (en) 2004-12-23
EP1641803B1 (de) 2009-03-18
CA2528848A1 (en) 2004-12-23
ES2324536T7 (es) 2012-03-16
WO2004111057A1 (en) 2004-12-23
EP1641803B3 (de) 2010-12-08
KR20060057539A (ko) 2006-05-26
CN1823071A (zh) 2006-08-23
HK1093064A1 (en) 2007-02-23
BRPI0411239A (pt) 2006-07-18

Similar Documents

Publication Publication Date Title
DE602004020070D1 (de) Thienopyrimidin-derivate als kaliumkanal-inhibitoren
IL260127B (en) mek inhibitors and methods of using them
SE0301700D0 (sv) Novel compounds
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
ATE527251T1 (de) Bicyclische derivate als modulatoren von ionenkanälen
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
ATE532789T1 (de) Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
EA201170344A1 (ru) Азаиндольные ингибиторы iap
NO20054723L (no) Behandling av proliferative sykdommer med epofilonderivater og straling
BRPI0415355A (pt) triarilimidazóis
DE60213798D1 (de) Carbolinderivate als pdev inhibitoren
UA96742C2 (en) Mek inhibitors and use thereof
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
EA201990219A3 (ru) Ингибиторы mek и способы их применения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition